Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SkyZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine), By Region, And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Market Segmentation and Scope
                       1.1.1 segment scope
                       1.1.2 regional scope
                       1.1.3 Estimates and Forecast Timeline
                 1.2 Research Methodology
                 1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 Secondary Sources
                       1.3.3 Primary Research
                       1.3.4 GVR’s Internal Database
                 1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                 1.5 Market Formulation & Validation
                 1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                             1.6.1.1 Approach: Commodity Flow Approach
                 1.7 Global Market: CAGR Calculation
                 1.8 List of Secondary Sources
                 1.9 List of Abbreviations
                 1.10 Objectives
                       1.10.1 Objective 1
                       1.10.2 objective 2
Chapter 2 Executive Summary
                 2.1 Market Outlook
Chapter 3 Shingles Vaccine Market Variables, Trends & Scope
                 3.1 Shingles Vaccine Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Ancillary market
                 3.2 Penetration & Growth Prospect Mapping
                 3.3 Market Dynamics
                       3.3.1 Market driver analysis
                             3.3.1.1 Increasing risk of developing shingles
                             3.3.1.2 Increase in the recommendation of shingles vaccination
                             3.3.1.3 Cost-effectiveness of vaccination
                       3.3.2 Market restraint analysis
                             3.3.2.1 Low awareness regarding shingles
                             3.3.2.2 Weak product pipeline
                 3.4 Clinical Laboratory Services Market Analysis Tools
                       3.4.1 Porter’s Five Forces Analysis
                       3.4.2 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
                             3.4.2.1 Political And Legal
                             3.4.2.2 Economic & Social
                             3.4.2.3 Technological
Chapter 4 Shingles Vaccine Market: Segment Analysis, By Product, 2017 - 2028 (USD Million)
                 4.1 Shingles Vaccine Market: Product Movement Analysis
                       4.1.1 Shingrix
                             4.1.1.1 Shingrix market estimates and forecast, 2017 - 2028
                       4.1.2 Zostavax
                             4.1.2.1 Zostavax market estimates and forecast, 2017 - 2028
                       4.1.3 SKYZoster
                             4.1.3.1 SKYZoster market estimates and forecast, 2017 - 2028
Chapter 5 Shingles Vaccine Market: Segment Analysis, By Vaccine Type, 2017 - 2028 (USD Million)
                 5.1 Shingles Vaccine Market: Vaccine Type Movement Analysis
                       5.1.1 Recombinant vaccine
                             5.1.1.1 Recombinant vaccine market estimates and forecast, 2017 - 2028
                       5.1.2 Live attenuated Vaccine
                             5.1.2.1 Live attenuated vaccine market estimates and forecast, 2017 - 2028
Chapter 6 Shingles Vaccine Market: Segment Analysis, By Region, 2017 - 2028 (USD Million)
                 6.1 Shingles Vaccine Market: Regional Movement Analysis
                       6.1.1 North America
                       6.1.2 North America, SWOT Analysis
                             6.1.2.1 North America market estimates and forecast, 2017 - 2028
                             6.1.2.2 U.S.
                                   6.1.2.2.1 U.S. market estimates and forecast, 2017 - 2028
                             6.1.2.3 Canada
                                   6.1.2.3.1 Canada market estimates and forecast, 2017 - 2028
                       6.1.3 Europe
                       6.1.4 Europe, SWOT Analysis
                             6.1.4.1 Europe market estimates and forecast, 2017 - 2028
                             6.1.4.2 U.K.
                                   6.1.4.2.1 U.K. market estimates and forecast, 2017 - 2028
                             6.1.4.3 Germany
                                   6.1.4.3.1 Germany market estimates and forecast, 2017 - 2028
                             6.1.4.4 France
                                   6.1.4.4.1 France market estimates and forecast, 2017 - 2028
                             6.1.4.5 Spain
                                   6.1.4.5.1 Spain market estimates and forecast, 2017 - 2028
                             6.1.4.6 Italy
                                   6.1.4.6.1 Italy market estimates and forecast, 2017 - 2028
                       6.1.5 Asia Pacific
                       6.1.6 Asia Pacific, SWOT Analysis
                             6.1.6.1 Asia Pacific market estimates and forecast, 2017 - 2028
                             6.1.6.2 Japan
                                   6.1.6.2.1 Japan market estimates and forecast, 2017 - 2028
                             6.1.6.3 China
                                   6.1.6.3.1 China market estimates and forecast, 2017 - 2028
                             6.1.6.4 Australia
                                   6.1.6.4.1 Australia market estimates and forecast, 2017 - 2028
                             6.1.6.5 South Korea
                                   6.1.6.5.1 South Korea market estimates and forecast, 2017 - 2028
                       6.1.7 Latin America
                       6.1.8 Latin America, SWOT Analysis
                             6.1.8.1 Latin America market estimates and forecast, 2017 - 2028
                             6.1.8.2 Brazil
                                   6.1.8.2.1 Brazil market estimates and forecast, 2017 - 2028
                             6.1.8.3 Mexico
                                   6.1.8.3.1 Mexico market estimates and forecast, 2017 - 2028
                       6.1.9 Middle East and Africa
                       6.1.10 Middle East & Africa, SWOT Analysis
                       6.1.11 Middle East & Africa market estimates and forecast, 2017 - 2028
                             6.1.11.1 South Africa
                                   6.1.11.1.1 South Africa market estimates and forecast, 2017 - 2028
Chapter 7 Competitive Landscape
                 7.1 Recent Developments & Impact Analysis, By Key Market Participants
                       7.1.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
                             7.1.1.1 Vendor Landscape
                                   7.1.1.1.1 Key company market share analysis, 2020
                             7.1.1.2 Public Companies
                                   7.1.1.2.1 Company market position analysis, 2020
                                   7.1.1.2.2 Competitive dashboard analysis
                                   7.1.1.2.3 Synergy analysis: Major deals and strategic alliances
                 7.2 Company Profiles
                       7.2.1 GlaxoSmithKline plc.
                             7.2.1.1 Company overview
                             7.2.1.2 Financial performance
                             7.2.1.3 Product benchmarking
                             7.2.1.4 Strategic initiatives
                       7.2.2 Merck & Co., Inc.
                             7.2.2.1 Company overview
                             7.2.2.2 Financial performance
                             7.2.2.3 Product benchmarking
                             7.2.2.4 Strategic initiatives
                       7.2.3 SK chemicals
                             7.2.3.1 Company overview
                             7.2.3.2 Financial performance
                             7.2.3.3 Product benchmarking
                             7.2.3.4 Strategic initiatives
                       7.2.4 Green Cross Corp
                             7.2.4.1 Company overview
                             7.2.4.2 Curevo Vaccine
                             7.2.4.3 Financial performance
                             7.2.4.4 Product benchmarking
                             7.2.4.5 Strategic initiatives
                       7.2.5 CanSinoBIO
                             7.2.5.1 Company overview
                             7.2.5.2 Financial performance
                             7.2.5.3 Product benchmarking
                             7.2.5.4 Strategic initiatives
                       7.2.6 Geneone Life Science
                             7.2.6.1 Company overview
                             7.2.6.2 Product benchmarking
                             7.2.6.3 Strategic initiatives
                       7.2.7 Vaccitech
                             7.2.7.1 Company overview
                             7.2.7.2 Product benchmarking
                             7.2.7.3 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 North America Shingles Vaccine Market, By Country, 2017 - 2028 (USD Million)
Table 4 North America Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 5 North America Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 6 U.S. Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 7 U.S. Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 8 Canada Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 9 Canada Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 10 Europe Shingles Vaccine Market, By Country, 2017 - 2028 (USD Million)
Table 11 Europe Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 12 Europe Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 13 Germany Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 14 Germany Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 15 U.K. Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 16 U.K. Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 17 France Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 18 France Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 19 Italy Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 20 Italy Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 21 Spain Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 22 Spain Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 23 Asia Pacific Shingles Vaccine Market, By Country, 2017 - 2028 (USD Million)
Table 24 Asia Pacific Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 25 Asia Pacific Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 26 Japan Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 27 Japan Shingles Vaccine Market, By Vaccine Type 2017 - 2028 (USD Million)
Table 28 China Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 29 China Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 30 Australia Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 31 Australia Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 32 South Korea Shingles Vaccine Market, By Product 2017 - 2028 (USD Million)
Table 33 South Korea Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 34 Latin America Shingles Vaccine Market, By Country, 2017 - 2028 (USD Million)
Table 35 Latin America Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 36 Latin America Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 37 Brazil Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 38 Brazil Shingles Vaccine Market, By Vaccine Type 2017 - 2028 (USD Million)
Table 39 Mexico Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 40 Mexico Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 41 Middle East & Africa Shingles Vaccine Market, By Country, 2017 - 2028 (USD Million)
Table 42 Middle East & Africa Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 43 Middle East & Africa Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)
Table 44 South Africa Shingles Vaccine Market, By Product, 2017 - 2028 (USD Million)
Table 45 South Africa Shingles Vaccine Market, By Vaccine Type, 2017 - 2028 (USD Million)

List of Figures

Fig. 1 Penetration & growth prospect mapping
Fig. 2 Market driver relevance analysis (Current & future impact)
Fig. 3 Market restrain relevance analysis (Current & future impact)
Fig. 4 Porter’s five forces analysis
Fig. 5 Shingles vaccine market: Product outlook and key takeaways
Fig. 6 Shingles vaccine market: Product movement analysis
Fig. 7 Shingrix market estimates and forecast, 2017 - 2028
Fig. 8 Zostavax market estimates and forecast, 2017 - 2028
Fig. 9 SkyZoster market estimates and forecast, 2017 - 2028
Fig. 10 Shingles vaccine market: Vaccine type outlook and key takeaways
Fig. 11 Shingles vaccine market: Vaccine type movement analysis
Fig. 12 Recombinant vaccine market estimates and forecast, 2017 - 2028
Fig. 13 Live attenuated vaccine market estimates and forecast, 2017 - 2028
Fig. 14 Shingles vaccine market: Regional outlook and key takeaways
Fig. 15 Shingles vaccine market: Regional movement analysis
Fig. 16 North America
Fig. 17 North America, SWOT
Fig. 18 North America. market estimates and forecast, 2017 - 2028
Fig. 19 U.S.
Fig. 20 U.S. market estimates and forecast, 2017 - 2028
Fig. 21 Canada
Fig. 22 Canada market estimates and forecast, 2017 - 2028
Fig. 23 Europe
Fig. 24 Europe, SWOT
Fig. 25 Europe market estimates and forecast, 2017 - 2028
Fig. 26 U.K.
Fig. 27 U.K. market estimates and forecast, 2017 - 2028
Fig. 28 Germany
Fig. 29 Germany market estimates and forecast, 2017 - 2028
Fig. 30 France
Fig. 31 France market estimates and forecast, 2017 - 2028
Fig. 32 Spain
Fig. 33 Spain market estimates and forecast, 2017 - 2028
Fig. 34 Italy
Fig. 35 Italy market estimates and forecast, 2017 - 2028
Fig. 36 Asia Pacific
Fig. 37 Asia Pacific, SWOT
Fig. 38 Asia Pacific market estimates and forecast, 2017 - 2028
Fig. 39 Japan
Fig. 40 Japan market estimates and forecast, 2017 - 2028
Fig. 41 China
Fig. 42 China market estimates and forecast, 2017 - 2028
Fig. 43 Australia
Fig. 44 Australia market estimates and forecast, 2017 - 2028
Fig. 45 South Korea
Fig. 46 South Korea market estimates and forecast, 2017 - 2028
Fig. 47 Latin America
Fig. 48 Latin America, SWOT
Fig. 49 Latin America. market estimates and forecast, 2017 - 2028
Fig. 50 Brazil
Fig. 51 Brazil market estimates and forecast, 2017 - 2028
Fig. 52 Mexico
Fig. 53 Mexico market estimates and forecast, 2017 - 2028
Fig. 54 Middle East & Africa
Fig. 55 Middle East & Africa, SWOT
Fig. 56 MEA market estimates and forecast, 2017 - 2028
Fig. 57 South Africa
Fig. 58 South Africa market estimates and forecast, 2017 - 2028